Global Endorphins Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
- BMR3856527
- 119 Pages
- May 2020
- Healthcare
Prior to COVID-19, the global market for Endorphins was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Endorphins is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Endorphins market.
In terms of production side, this report researches the Endorphins production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Endorphins by regions (countries) and by Application.
The global Endorphins market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Endorphins market. These figures have been provided in terms of both revenue and volume for the period 2015-2026. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Endorphins market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Endorphins industry.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Endorphins markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2015-2025, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Endorphins market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Endorphins market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Endorphins market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2015-2020.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Endorphins market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Endorphins market by each type segment for the period 2015-2025. It also offers volume sales (consumption) analysis and forecast of the global Endorphins market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Endorphins market by each application segment for the same period.
This report includes the following manufacturers:
Assertio Therapeutics Inc.
Cipher Pharmaceuticals Inc.
Endo International Plc
Egalet Corp.
Lannett Co. Inc.
Pfizer
Johnson & Johnson
...
Market Segment by Type
Alpha-Endorphins
Beta-Endorphins
Gamma-Endorphins
Sigma-Endorphins
Market Segment by Application
Institutional Pharmacies
Retail Pharmacies
Online Pharmacies
Research Methodology
To compile the detailed study of the global Endorphins market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Endorphins market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Endorphins market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1.1 Research Scope
1.2 Top Endorphins Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Endorphins Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Alpha-Endorphins
1.3.3 Beta-Endorphins
1.3.4 Gamma-Endorphins
1.3.5 Sigma-Endorphins
1.4 Market Segment by Application
1.4.1 Global Endorphins Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Institutional Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 Study Objectives
1.7 Years Considered
2 Global Market Perspective
2.1 Global Endorphins Revenue (2015-2026)
2.1.1 Global Endorphins Revenue (2015-2026)
2.1.2 Global Endorphins Sales (2015-2026)
2.2 Covid-19 Impact on Global Endorphins Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Endorphins Sales by Regions (2015-2020)
2.2.2 Global Endorphins Revenue by Regions (2015-2020)
2.3 Global Top Endorphins Regions (Countries) Ranking by Market Size
2.4 Endorphins Industry Trends
2.4.1 Covid-19 Impact: Endorphins Market Trends
2.4.2 Covid-19 Impact: Endorphins Market Drivers
2.4.3 Covid-19 Impact: Endorphins Market Challenges
2.4.4 Covid-19 Impact: Endorphins Market Restraints
2.4.5 Primary Interviews with Key Endorphins Players: Views for Future
3 Covid-19 Impact on Competitive Landscape by Manufacturers
3.1 Global Top Endorphins Manufacturers by Sales (2015-2020)
3.1.1 Global Endorphins Sales by Manufacturers (2015-2020)
3.1.2 Global Endorphins Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Endorphins Sales in 2019
3.2 Global Top Manufacturers Endorphins by Revenue
3.2.1 Global Endorphins Revenue by Manufacturers (2015-2020)
3.2.2 Global Endorphins Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Endorphins Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endorphins as of 2019)
3.4 Global Endorphins Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Endorphins Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Endorphins Market
3.7 Key Manufacturers Endorphins Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Impact on Market Size by Type
4.1 Global Endorphins Historic Market Review by Type (2015-2020)
4.1.2 Global Endorphins Sales Market Share by Type (2015-2020)
4.1.3 Global Endorphins Revenue Market Share by Type (2015-2020)
4.1.4 Endorphins Price by Type (2015-2020)
4.1 Global Endorphins Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Endorphins Sales Forecast by Type (2021-2026)
4.2.3 Global Endorphins Revenue Forecast by Type (2021-2026)
4.2.4 Endorphins Price Forecast by Type (2021-2026)
5 Covid-19 Impact on Global Endorphins Market Size by Application
5.1 Global Endorphins Historic Market Review by Application (2015-2020)
5.1.2 Global Endorphins Sales Market Share by Application (2015-2020)
5.1.3 Global Endorphins Revenue Market Share by Application (2015-2020)
5.1.4 Endorphins Price by Application (2015-2020)
5.2 Global Endorphins Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Endorphins Sales Forecast by Application (2021-2026)
5.2.3 Global Endorphins Revenue Forecast by Application (2021-2026)
5.2.4 Endorphins Price Forecast by Application (2021-2026)
6 North America
6.1 North America Endorphins Breakdown Data by Company
6.2 North America Endorphins Breakdown Data by Type
6.3 North America Endorphins Breakdown Data by Application
6.4 North America Endorphins Breakdown Data by Countries
6.4.1 North America Endorphins Sales by Countries
6.4.2 North America Endorphins Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Endorphins Breakdown Data by Company
7.2 Europe Endorphins Breakdown Data by Type
7.3 Europe Endorphins Breakdown Data by Application
7.4 Europe Endorphins Breakdown Data by Countries
7.4.1 Europe Endorphins Sales by Countries
7.4.2 Europe Endorphins Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Endorphins Breakdown Data by Company
8.2 Asia Pacific Endorphins Breakdown Data by Type
8.3 Asia Pacific Endorphins Breakdown Data by Application
8.4 Asia Pacific Endorphins Breakdown Data by Regions
8.4.1 Asia Pacific Endorphins Sales by Regions
8.4.2 Asia Pacific Endorphins Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Endorphins Breakdown Data by Company
9.2 Latin America Endorphins Breakdown Data by Type
9.3 Latin America Endorphins Breakdown Data by Application
9.4 Latin America Endorphins Breakdown Data by Countries
9.4.1 Latin America Endorphins Sales by Countries
9.4.2 Latin America Endorphins Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Endorphins Breakdown Data by Type
10.2 Middle East and Africa Endorphins Breakdown Data by Application
10.3 Middle East and Africa Endorphins Breakdown Data by Countries
10.3.1 Middle East and Africa Endorphins Sales by Countries
10.3.2 Middle East and Africa Endorphins Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 Assertio Therapeutics Inc.
11.1.1 Assertio Therapeutics Inc. Corporation Information
11.1.2 Assertio Therapeutics Inc. Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Assertio Therapeutics Inc. Endorphins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Assertio Therapeutics Inc. Endorphins Products and Services
11.1.5 Assertio Therapeutics Inc. SWOT Analysis
11.1.6 Assertio Therapeutics Inc. Recent Developments and Reaction to Covid-19
11.2 Cipher Pharmaceuticals Inc.
11.2.1 Cipher Pharmaceuticals Inc. Corporation Information
11.2.2 Cipher Pharmaceuticals Inc. Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Cipher Pharmaceuticals Inc. Endorphins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Cipher Pharmaceuticals Inc. Endorphins Products and Services
11.2.5 Cipher Pharmaceuticals Inc. SWOT Analysis
11.2.6 Cipher Pharmaceuticals Inc. Recent Developments and Reaction to Covid-19
11.3 Endo International Plc
11.3.1 Endo International Plc Corporation Information
11.3.2 Endo International Plc Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Endo International Plc Endorphins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Endo International Plc Endorphins Products and Services
11.3.5 Endo International Plc SWOT Analysis
11.3.6 Endo International Plc Recent Developments and Reaction to Covid-19
11.4 Egalet Corp.
11.4.1 Egalet Corp. Corporation Information
11.4.2 Egalet Corp. Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Egalet Corp. Endorphins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Egalet Corp. Endorphins Products and Services
11.4.5 Egalet Corp. SWOT Analysis
11.4.6 Egalet Corp. Recent Developments and Reaction to Covid-19
11.5 Lannett Co. Inc.
11.5.1 Lannett Co. Inc. Corporation Information
11.5.2 Lannett Co. Inc. Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Lannett Co. Inc. Endorphins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Lannett Co. Inc. Endorphins Products and Services
11.5.5 Lannett Co. Inc. SWOT Analysis
11.5.6 Lannett Co. Inc. Recent Developments and Reaction to Covid-19
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Pfizer Endorphins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Pfizer Endorphins Products and Services
11.6.5 Pfizer SWOT Analysis
11.6.6 Pfizer Recent Developments and Reaction to Covid-19
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Johnson & Johnson Endorphins Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Endorphins Products and Services
11.7.5 Johnson & Johnson SWOT Analysis
11.7.6 Johnson & Johnson Recent Developments and Reaction to Covid-19
12 Covid-19 Impact on Value Chain and Sales Channels Analysis
12.1 Covid-19 Impact on Endorphins Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Endorphins Sales Channels
12.2.2 Endorphins Distributors
12.3 Endorphins Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Endorphins Sales Forecast (2021-2026)
13.1.1 Global Endorphins Sales Forecast by Regions (2021-2026)
13.1.2 Global Endorphins Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Endorphins Sales Forecast (2021-2026)
13.2.2 North America Endorphins Revenue Forecast (2021-2026)
13.2.3 North America Endorphins Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Endorphins Sales Forecast (2021-2026)
13.3.2 Europe Endorphins Revenue Forecast (2021-2026)
13.3.3 Europe Endorphins Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Endorphins Sales Forecast (2021-2026)
13.4.2 Asia Pacific Endorphins Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Endorphins Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Endorphins Sales Forecast (2021-2026)
13.5.2 Latin America Endorphins Revenue Forecast (2021-2026)
13.5.3 Latin America Endorphins Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Endorphins Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Endorphins Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Endorphins Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Endorphins Key Market Segments
Table 2. Ranking of Global Top Endorphins Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Endorphins Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Alpha-Endorphins
Table 5. Major Manufacturers of Beta-Endorphins
Table 6. Major Manufacturers of Gamma-Endorphins
Table 7. Major Manufacturers of Sigma-Endorphins
Table 8. Global Endorphins Market Share by Application 2019-2025 (K Units)
Table 9. COVID-19 Impact Global Market: (Four Endorphins Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Endorphins Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Endorphins Players to Combat Covid-19 Impact
Table 14. Global Endorphins Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 15. Global Endorphins Sales by Regions 2015-2020 (K Units)
Table 16. Global Endorphins Sales Market Share by Regions 2015-2020
Table 17. Global Endorphins Revenue by Regions 2015-2020 (Million US$)
Table 18. Global Endorphins Revenue Market Share by Regions 2015-2020
Table 19. Top Endorphins Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 20. Market Top Trends
Table 21. Endorphins Key Drivers: Impact Analysis (2021-2026)
Table 22. Endorphins Key Challenges
Table 23. Main Points Interviewed from Key Endorphins Players: Views for Future
Table 24. Global Endorphins Sales by Manufacturers (2015-2020) (K Units)
Table 25. Global Endorphins Sales Share by Manufacturers (2015-2020)
Table 26. Endorphins Revenue by Manufacturers (2015-2020) (Million US$)
Table 27. Endorphins Revenue Share by Manufacturers (2015-2020)
Table 28. Global Endorphins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endorphins as of 2019)
Table 30. Key Manufacturers Endorphins Average Selling Price (ASP) (2015-2020) (US$/Unit)
Table 31. Key Manufacturers Endorphins Plants/Factories Distribution
Table 32. Key Manufacturers Endorphins Area Served
Table 33. Date of Key Manufacturers Enter into Endorphins Market
Table 34. Key Manufacturers Endorphins Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Alpha-Endorphins Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 37. Global Beta-Endorphins Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 38. Global Gamma-Endorphins Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 39. Global Sigma-Endorphins Sales ana Revenue (2015-2020) (K Units) & (Million US$)
Table 40. Global Endorphins Sales (K Units) by Type (2015-2020)
Table 41. Global Endorphins Sales Share by Type (2015-2020)
Table 42. Global Endorphins Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. Global Endorphins Price (K Units) by Type (2015-2020)
Table 44. Global Endorphins Sales (K Units) by Type (2021-2026)
Table 45. Global Endorphins Sales Share by Type (2021-2026)
Table 46. Global Endorphins Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. Global Endorphins Revenue Share by Type (2021-2026)
Table 48. Global Endorphins Price (K Units) by Type (2021-2026)
Table 49. Global Endorphins Sales (K Units) by Application (2015-2020)
Table 50. Global Endorphins Sales Share by Application (2015-2020)
Table 51. Global Endorphins Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. Global Endorphins Price by Application 2015-2020 (US$/Unit)
Table 53. Global Endorphins Sales by Application (2015-2020) (K Units)
Table 54. Global Endorphins Sales Share by Application (2015-2020)
Table 55. Global Endorphins Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Global Endorphins Revenue Share by Application (2021-2026)
Table 57. Global Endorphins Price (K Units) by Application (2021-2026)
Table 58. North America Endorphins Sales by Company (2015-2020) (K Units)
Table 59. North America Endorphins Sales Market Share by Company (2015-2020)
Table 60. North America Endorphins Sales by Type (2015-2020) (K Units)
Table 61. North America Endorphins Sales Market Share by Type (2015-2020)
Table 62. North America Endorphins Sales by Application (2015-2020) (K Units)
Table 63. North America Endorphins Sales Market Share by Application (2015-2020)
Table 64. North America Endorphins Sales by Countries (2015-2020) (K Units)
Table 65. North America Endorphins Sales Market Share by Countries (2015-2020)
Table 66. North America Endorphins Revenue by Countries (2015-2020) (Million US$)
Table 67. North America Endorphins Revenue Market Share by Countries (2015-2020)
Table 68. Europe Endorphins Sales by Company (2015-2020) (K Units)
Table 69. Europe Endorphins Sales Market Share by Company (2015-2020)
Table 70. Europe Endorphins Sales by Type (2015-2020) (K Units)
Table 71. Europe Endorphins Sales Market Share by Type (2015-2020)
Table 72. Europe Endorphins Sales by Application (2015-2020) (K Units)
Table 73. Europe Endorphins Sales Market Share by Application (2015-2020)
Table 74. Europe Endorphins Sales by Countries (2015-2020) (K Units)
Table 75. Europe Endorphins Sales Market Share by Countries (2015-2020)
Table 76. Europe Endorphins Revenue by Countries (2015-2020) (Million US$)
Table 77. Europe Endorphins Revenue Market Share by Countries (2015-2020)
Table 78. Asia Pacific Endorphins Sales by Regions (2015-2020) (K Units)
Table 79. Asia Pacific Endorphins Sales Market Share by Regions (2015-2020)
Table 80. Asia Pacific Endorphins Sales by Type (2015-2020) (K Units)
Table 81. Asia Pacific Endorphins Sales Market Share by Type (2015-2020)
Table 82. Asia Pacific Endorphins Sales by Application (2015-2020) (K Units)
Table 83. Asia Pacific Endorphins Sales Market Share by Application (2015-2020)
Table 84. Asia Pacific Endorphins Sales by Countries (2015-2020) (K Units)
Table 85. Asia Pacific Endorphins Sales Market Share by Regions (2015-2020)
Table 86. Asia Pacific Endorphins Revenue by Regions (2015-2020) (Million US$)
Table 87. Asia Pacific Endorphins Revenue Market Share by Regions (2015-2020)
Table 88. Latin America Endorphins Sales by Company (2015-2020) (K Units)
Table 89. Latin America Endorphins Sales Market Share by Company (2015-2020)
Table 90. Latin America Endorphins Sales by Type (2015-2020) (K Units)
Table 91. Latin America Endorphins Sales Market Share by Type (2015-2020)
Table 92. Latin America Endorphins Sales by Application (2015-2020) (K Units)
Table 93. Latin America Endorphins Sales Market Share by Application (2015-2020)
Table 94. Latin America Endorphins Sales by Countries (2015-2020) (K Units)
Table 95. Latin America Endorphins Sales Market Share by Countries (2015-2020)
Table 96. Latin America Endorphins Revenue by Countries (2015-2020) (Million US$)
Table 97. Latin America Endorphins Revenue Market Share by Countries (2015-2020)
Table 98. Middle East and Africa Endorphins Sales by Type (2015-2020) (K Units)
Table 99. Middle East and Africa Endorphins Sales Market Share by Type (2015-2020)
Table 100. Middle East and Africa Endorphins Sales by Application (2015-2020) (K Units)
Table 101. Middle East and Africa Endorphins Sales Market Share by Application (2015-2020)
Table 102. Middle East and Africa Endorphins Sales by Countries (2015-2020) (K Units)
Table 103. Middle East and Africa Endorphins Sales Market Share by Countries (2015-2020)
Table 104. Middle East and Africa Endorphins Revenue by Countries (2015-2020) (Million US$)
Table 105. Middle East and Africa Endorphins Revenue Market Share by Countries (2015-2020)
Table 106. Assertio Therapeutics Inc. Company Details
Table 107. Assertio Therapeutics Inc. Description and Business Overview
Table 108. Assertio Therapeutics Inc. Endorphins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 109. Assertio Therapeutics Inc. Endorphins Sales Growth Rate (2015-2020)
Table 110. Assertio Therapeutics Inc. Endorphins Sales Market Share in Global Market
Table 111. Assertio Therapeutics Inc. Recent Development
Table 112. Cipher Pharmaceuticals Inc. Company Details
Table 113. Cipher Pharmaceuticals Inc. Description and Business Overview
Table 114. Cipher Pharmaceuticals Inc. Endorphins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 115. Cipher Pharmaceuticals Inc. Endorphins Sales Growth Rate (2015-2020)
Table 116. Cipher Pharmaceuticals Inc. Endorphins Sales Market Share in Global Market
Table 117. Cipher Pharmaceuticals Inc. Recent Development
Table 118. Endo International Plc Company Details
Table 119. Endo International Plc Description and Business Overview
Table 120. Endo International Plc Endorphins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 121. Endo International Plc Endorphins Sales Growth Rate (2015-2020)
Table 122. Endo International Plc Endorphins Sales Market Share in Global Market
Table 123. Endo International Plc Recent Development
Table 124. Egalet Corp. Company Details
Table 125. Egalet Corp. Description and Business Overview
Table 126. Egalet Corp. Endorphins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 127. Egalet Corp. Endorphins Sales Growth Rate (2015-2020)
Table 128. Egalet Corp. Endorphins Sales Market Share in Global Market
Table 129. Egalet Corp. Recent Development
Table 130. Lannett Co. Inc. Company Details
Table 131. Lannett Co. Inc. Description and Business Overview
Table 132. Lannett Co. Inc. Endorphins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 133. Lannett Co. Inc. Endorphins Sales Growth Rate (2015-2020)
Table 134. Lannett Co. Inc. Endorphins Sales Market Share in Global Market
Table 135. Lannett Co. Inc. Recent Development
Table 136. Pfizer Company Details
Table 137. Pfizer Description and Business Overview
Table 138. Pfizer Endorphins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 139. Pfizer Endorphins Sales Growth Rate (2015-2020)
Table 140. Pfizer Endorphins Sales Market Share in Global Market
Table 141. Pfizer Recent Development
Table 142. Johnson & Johnson Company Details
Table 143. Johnson & Johnson Description and Business Overview
Table 144. Johnson & Johnson Endorphins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 145. Johnson & Johnson Endorphins Sales Growth Rate (2015-2020)
Table 146. Johnson & Johnson Endorphins Sales Market Share in Global Market
Table 147. Johnson & Johnson Recent Development
Table 148. Endorphins Distributors List
Table 149. Endorphins Customers List
Table 150. Global Endorphins Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 151. Global Endorphins Sales Forecast by Type 2021-2026 (K Units)
Table 152. Global Endorphins Sales Forecast by Application 2021-2026 (K Units)
Table 153. Global Endorphins Sales Forecast by Regions 2021-2026 (K Units)
Table 154. Global Endorphins Revenue Forecast by Regions 2021-2026 (Million US$)
Table 155. North America Endorphins Sales Forecast by Countries 2021-2026 (K Units)
Table 156. North America Endorphins Revenue Forecast by Countries 2021-2026
Table 157. Europe Endorphins Sales Forecast by Countries 2021-2026 (K Units)
Table 158. Europe Endorphins Revenue Market Share Forecast by Countries 2021-2026
Table 159. Asia Pacific Endorphins Sales Forecast by Regions 2021-2026 (K Units)
Table 160. Asia Pacific Endorphins Revenue Forecast by Regions 2021-2026 (Million US$)
Table 161. Latin America Endorphins Sales Forecast by Countries 2021-2026 (K Units)
Table 162. Latin America Endorphins Revenue Forecast by Countries 2021-2026 (Million US$)
Table 163. Middle East and Africa Endorphins Sales Forecast by Regions 2021-2026 (K Units)
Table 164. Middle East and Africa Endorphins Revenue Forecast by Regions 2021-2026 (Million US$)
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Endorphins Product Picture
Figure 2. Global Endorphins Sales Market Shar by Type 2015-2026
Figure 3. Alpha-Endorphins Figures
Figure 4. Beta-Endorphins Figures
Figure 5. Gamma-Endorphins Figures
Figure 6. Sigma-Endorphins Figures
Figure 7. Global Endorphins Sales Market Share by Application in 2019 & 2026
Figure 8. Institutional Pharmacies Use Case
Figure 9. Retail Pharmacies Use Case
Figure 10. Online Pharmacies Use Case
Figure 11. Endorphins Report Years Considered
Figure 12. Global Endorphins Market Size 2015-2026 (Million US$)
Figure 13. Global Endorphins Sales 2015-2020 (K Units)
Figure 14. Global Endorphins Market Size Market Share by Regions 2015-2020
Figure 15. Global Endorphins Sales Market Share by Regions in 2019
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Endorphins Sales Share by Manufacturers in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Endorphins Sales in 2019
Figure 19. Endorphins Value Share by Manufacturers in 2019
Figure 20. Endorphins Revenue Share by Manufacturers In 2019
Figure 21. Endorphins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Endorphins Revenue Share by Type (2015-2020)
Figure 23. Global Endorphins Revenue Growth Rate by Type in 2015 & 2019
Figure 24. Global Endorphins Market Share by Price Range (2015-2020)
Figure 25. Global Endorphins Revenue Share by Application (2015-2020)
Figure 26. Global Endorphins Revenue Growth Rate by Application in 2015 & 2019
Figure 27. North America Endorphins Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. U.S. Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 29. Canada Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 30. Europe Endorphins Revenue Growth Rate 2015-2020 (Million US$)
Figure 31. Germany Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 35. Russia Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 36. Asia Pacific Endorphins Revenue Growth Rate 2015-2020 (Million US$)
Figure 37. China Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 38. Japan Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 39. South Korea Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 40. India Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 41. Australia Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 42. Taiwan Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 43. Indonesia Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 44. Thailand Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 45. Malaysia Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 46. Philippines Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 47. Vietnam Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 48. Latin America Endorphins Revenue Growth Rate 2015-2020 (Million US$)
Figure 49. Mexico Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 50. Brazil Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 51. Argentina Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 52. Middle East and Africa Endorphins Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Turkey Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 54. Saudi Arabia Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.A.E Endorphins Sales Growth Rate (2015-2020) (K Units)
Figure 56. Assertio Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Cipher Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Endo International Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Egalet Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Lannett Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Endorphins Value Chain
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. North America Endorphins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. North America Endorphins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Europe Endorphins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 69. Europe Endorphins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Asia Pacific Endorphins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 71. Asia Pacific Endorphins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Latin America Endorphins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 73. Latin America Endorphins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Middle East and Africa Endorphins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 75. Middle East and Africa Endorphins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
